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Takayasu’s arteritis is an inflammatory vasculitis that primarily affects the aorta and its major branches. Involvement 
of the thoracic and abdominal aortas, although rare, causes marked hypertension and may lead to severe heart 
failure. We report the improvement of cardiac function after axillofemoral bypass grafting in a 59-year-old woman 
who had this condition.
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CASE REPORT
A  59-year-old  woman  who  had  pre-existing  hypertension 
presented with chest pain and dyspnea. She reported claudica-
tion  and  coldness  of  the  lower  extremities  that  had  been  be-
coming  more  severe.  Her  medical  history  included  a  diag-
nosis  of  hypertension.
On physical examination, she was found to be hypertensive 
in  the  right  arm  (170/100  mmHg),  normotensive  in  the  left 
arm  (100/60  mmHg),  and  hypotensive  in  the  thighs  (76/45 
mmHg).  Both  femoral  pulses  were  weak  and  the  ankle-bra-
chial  index  (ABI)  was  0.56.  There  were  no  remarkable  find-
ings  in  the  laboratory  tests  including  the  C-reactive  protein 
level  and  erythrocyte  sedimentation  rate.  A  12-lead  electro-
cardiogram  revealed  a  normal  sinus  rhythm  and  left  ven-
tricular  hypertrophy.  The  chest  X-ray  revealed  cardiomegaly 
(cardiothoracic  ratio  57.4%)  and  left  ventricular  enlargement. 
The  computed  tomography  findings,  such  as  diffuse  concen-
tric wall thickening, and luminal narrowing  of the  aorta  from 
the  thoracoabdominal  junction  to  the  infrarenal  level  along 
with  diffuse  stenosis  of the  left  renal  artery, were  compatible 
w i t h  t h e  p r e s u m e d  d i a g n o s i s  o f  T a k a y a s u ’ s  a r t e r i t i s .  T h e  l e f t  
ventricular ejection fraction assessed by echocardiography was 
25%.
For  treatment,  bypass  grafting  was  performed  between  the 
right  axillary  artery  and  the  right  femoral  artery  using  an  8 
mm ringed Gore-Tex graft (Fig. 1). Warfarin (2 mg/day) was 
administered  postoperatively.  At  the  time  of  discharge,  the 
patient  showed  marked  improvement  of  the  dyspnea  and 
chest pain. The ABI became normal (1.0) (Fig. 2). Echocardi-
ography  showed  early  improvement  of  the  left  ventricular 
ejection fraction (range, 23% to 41%) and dimensions (range, 
61/69  mm  to  52/62  mm)  compared  with  the  preoperative 
values. At 11 months, these indices had  improved further  ac-
cording  to  the  echocardiogram;  the  left  ventricular  ejection 
fraction  was  57%  and  the  dimensions  were  37/52  mm.Treated Takayasu’s Arteritis Using Axillofemoral Bypass
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Fig. 1. (A) Preoperative computed 
tomography (CT) showing marked ir-
regular narrowing of the descending 
thoracic and abdominal aortas. Diffu-
se concentric wall thickening and lu-
minal narrowing were also found in 
the left common and internal carotid, 
and the left subclavian arteries. (B) 
Postoperative CT showing a patent 
axillofemoral bypass graft.
Fig. 2. (A) Preoperative ankle-brach-
ial index (ABI) test showing marked 
decreases in both ABIs, with a pres-
sure difference between the arms. 
(B) Postoperative ABI test showing 
normal results. D=doppler; PT=poste-
rior tibial.
DISCUSSION
Takayasu’s  arteritis  is  a  chronic  inflammatory  disease  af-
fecting  the  aorta  and  its  main  branches.  Stenosis  involving 
both  the  thoracic  and  abdominal  portions  is  extremely  rare. 
Hypertension  can  increase  systemic  resistance,  causing  in-Ji Hyun Bang, et al
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creased  after-load  and  resulting  in  heart  failure.  Surgery  is 
generally  warranted  because  the  prognosis  is  poor  if  left 
untreated.  The  first  successful  resection  and  end-to-end  anas-
t o m o s i s  o f  s t e n o s i s  o f  t h e  a o r t a  w a s  p e r f o r m e d  b y  C r a f o o r d  
and Nylin [1] in October 1944. There are problems associated 
with  resection  and  anastomosis.  First  of  all,  aortic  restenosis 
can occur with the reported incidence between 1.5% and 43% 
[2].  In  addition,  the  intercostal  arteries  can  be  injured  due  to 
anatomical  distortion  caused  by  the  surrounding  scar  tissue, 
and spinal cord ischemia can also occur as the result of aort-
ic cross-clamping. In 1973, Weldon et al. [3] reported bypass 
grafting  as  an  alternative  to  resection  and  anastomosis  be-
cause  it  avoids  dissection  of  the  scar  tissue  and  aortic 
cross-clamping.  Since  then,  tube  bypass  grafting  has  been 
performed  in  various  ways  with  the  proximal  anastomosis  on 
the axillary artery or the ascending aorta, and the distal anas-
tomosis  on  the  descending  aorta  o r  t h e  f e m o r a l  a r t e r y  [ 2 , 4 ] .
Axillofemoral  bypass  has  been  a  widely  accepted  manage-
ment  approach  that  carries  a  low  risk  of  mortality  and 
morbidity.  Martin  and  Katz  [5]  reported  a  30-day  mortality 
rate of 4.9% and Schneider et al. [6] described a 30-day mor-
tality  rate  of  9%.  This  procedure  reduces  the  hemodynamic 
disturbances  that  accompany  aortic  resection  and  end-to-end 
anastomosis.  This  benefit  appears  to  be  the  result  of  the  re-
duction  of  cardiac  after-load,  reduction  of  spinal  cord  ische-
mia  by  avoiding  cephalic  hypertension  and  caudal  hypo-
tension,  and  preservation  of  renal  and  mesenteric  perfusion, 
thus  avoiding  the  need  for  heparin  in  many  patients.
However,  the  procedure’s  long-term  patency  is  contro-
versial.  The  patency  of  a  bypass  graft  can  be  affected  by 
multiple  factors  including  the  surgeon’s  experience,  surgical 
method,  and  the  material  and  si z e  o f  t h e  p r o s t h e t i c  g r a f t s .  
Martin and Katz [5] reported patency rates of 88% at 1 year, 
79%  at  3  years,  and  69%  at  5  years.
It  is  unlikely  that  aortoaortic  and  axillofemoral  bypass  will 
be  subjected  to  the  rigors  of  a  prospective  and  randomized 
study to compare their relative merits, and the current studies 
describing  the  results  of  these  bypass  operations  have  had 
dissimilar  patient  cohorts.  In  the  majority  of  series,  patients 
undergoing axillofemoral grafting were older, had more medi-
cal  comorbidities,  and  had  a  higher  number  of  operations  for 
limb  salvage  than  patients  undergoing  an  aorto-aortic  bypass.
As  the  age  of  the  population  increases  and  the  healthcare 
system  suffers  greater  economic  restraints,  these  factors  will 
become  increasingly  important  when  determining  treatment 
options.  We  believe  that  axillofemoral  bypass  grafting  is  a 
viable  alternative  to  direct  aortic  reconstruction  in  the  treat-
ment  of  patients  with  severe  cardiac  and  pulmonary  disease, 
with  highly  reproducible  3-year  and  5-year  patency  rates  [7]. 
Although  aortofemoral  bypass  remains  the  procedure  of 
choice in good-risk patients, axillofemoral grafting remains an 
excellent  therapeutic  option  for  surgeons  encountering  elderly 
or  debilitated  patients  with  diffuse  aortic  disease.
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